meta_pixel
Tapesearch Logo
Log in
Mad Money w/ Jim Cramer

Domino's CEO, Inovio Pharmaceuticals CEO, & Digging Into UNH

Mad Money w/ Jim Cramer

CNBC

News, Investing, Business

4.34K Ratings

🗓️ 23 April 2020

⏱️ 47 minutes

🧾️ Download transcript

Summary

Fresh off the company's top and bottom line beat, Cramer's checking in with the CEO of Domino's Pizza to learn more about how the company's delivering in a new environment. Then, after learning that Inovio Pharmaceuticals was one of the most-bought stocks on Robinhood in March, Cramer's talking to the company's CEO to learn more about its path towards finding a vaccine for COVID-19. Plus, Cramer's breaking down UnitedHealth Group's recent earnings to see if there are any insights investors should use to help in building their thesis.

Transcript

Click on a timestamp to play from that location

0:00.0

My mission is simple to make you money.

0:04.0

I'm here to level the playing field for all investors.

0:08.0

There's always a more market somewhere,

0:10.0

and I promised to help you find it.

0:12.0

Man money starts now.

0:20.0

Hey, I'm Kramer.

0:21.0

Welcome to Man Money.

0:22.0

Welcome to Kramer, America.

0:23.0

I'd be going to make friends.

0:25.0

I'm just trying to make you some money.

0:26.0

My job is not just to entertain but educate and teach you.

0:29.0

Call me at 1-800-743-CMBC or tweet me at chim Kramer.

0:33.0

We got to stop tonight.

0:35.0

Okay?

0:36.0

Stop thinking about the stock market as one discrete thing.

0:39.0

We have three markets.

0:42.0

Maybe even more.

0:44.0

After they were the Dow advanced 39 points.

0:46.0

S&P decline.05% and as I tip one basis point.

0:50.0

I want you to forget about the averages for a second,

0:52.0

or maybe for a week or a month or a year,

0:54.0

or until the end of the pandemic.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from CNBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of CNBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.